Relief Therapeutics Sees 60-70% Chance of COVID-19 Drug Approval

August 8, 2020August 8, 2020 THE COVID REMEDY trials

Its U.S. partner NeuroRx is running multicentre clinical trials https://relieftherapeutics.com/clinical-trials-2, including a Phase IIb/III trial in patients who are …

Source: Relief Therapeutics Sees 60-70% Chance of COVID-19 Drug Approval

← One of the world’s top COVID-19 vaccines is ‘stuck’ in customs—Is the delay deliberate?
New clinical trial adds multiple sclerosis drug to boost COVID-19 patients’ immune system →